MyFinsight
Home
Blog
About
Back
Income Statement
Polaryx Therapeutics, Inc. (PLYX)
Polaryx Therapeutics, Inc. (PLYX)
source: myfinsight.com
Net loss and
comprehensive loss
-$1,380K
Operating loss
-$1,380K
Total operating
expenses
$1,380K
Research and development
expenses
$719K
General and
administrative expenses
$661K
Back